Skip to content

Effects of Oxytocin on Uterine Atony

The Comparative Effects of Normal Oxytocin Dose with 80 Unit Dose on Preventing Uterine Atony after Cesarean Delivery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015020921015N1
Enrollment
150
Registered
2015-02-28
Start date
2014-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Atony after Cesarean Delivery. Atony of uterus

Interventions

oxytocin dose (30 and 80 UST unit in 500cc Ringer serum respectively for group one and two).
Treatment - Drugs
oxytocin dose (30 and 80 UST unit in 500cc Ringer serum respectively for group one and two)

Sponsors

Medical School, Zahedan University of Medical sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 39 Years

Inclusion criteria

Inclusion criteria: The women having the following risk factors of uterine atony were excluded from the study, such as more than seven parity, high blood pressure, preeclampsia, Multiple pregnancies,polyhydramnios,hemoglobin less than 10 mg per deci liter, systolic blood pressure less than 100 mmHg, placenta previa, those who have long surgery and need to blood transfusion,

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Uterine atony. Timepoint: after cesarean. Method of measurement: based on diagnostic test.

Secondary

MeasureTime frame
Hemoglobin drop. Timepoint: 6 hours and 24 hours after surgery (after oxytocin infusion). Method of measurement: based on test.;Need to extra uterotonic drug. Timepoint: after cesarean (after oxytocin infusion). Method of measurement: based on diagnostic test.;Systolic blood pressure (under 100 mm Hg). Timepoint: after cesarean (after oxytocin infusion). Method of measurement: based on test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatameh Ahmadi

Zahedan University of Medical sciences

fatamehahmadi@gmail.com+98 54 3329 5831

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026